ArticleCurrent oncology (Toronto, Ont.)2021

Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008-2012.

Malek Hannouf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.